AWHL — Aspira Womens Health Income Statement
0.000.00%
Last trade - 00:00- $14.50m
- $12.02m
- $9.18m
- 38
- 32
- 68
- 43
Annual income statement for Aspira Womens Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.65 | 6.81 | 8.18 | 9.15 | 9.18 |
| Cost of Revenue | |||||
| Gross Profit | 1.24 | 3.06 | 4.32 | 5.26 | 5.48 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 22.6 | 39.4 | 39.3 | 27 | 25.5 |
| Operating Profit | -18 | -32.6 | -31.1 | -17.9 | -16.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -17.9 | -31.7 | -29.9 | -16.7 | -13.1 |
| Net Income After Taxes | -17.9 | -31.7 | -29.9 | -16.7 | -13.1 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -17.9 | -31.7 | -29.9 | -16.7 | -13.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -17.9 | -31.7 | -29.9 | -16.7 | -13.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.67 | -4.27 | -3.91 | -1.92 | -0.926 |